1 – 100 of 362
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
EUFOREA/EPOS2020 statement on the clinical considerations for CRSwNP care
(
- Contribution to journal › Article
-
Mark
Metabolic pathways in immune senescence and inflammaging : Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology
(
- Contribution to journal › Article
-
Mark
Bronchodilator Responsiveness Measured by Spirometry and Impulse Oscillometry in Patients with Asthma After Short Acting Antimuscarinic and/or Beta-2-Agonists Inhalation
(
- Contribution to journal › Article
-
Mark
Reply to “Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry”
(
- Contribution to journal › Article
-
Mark
Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma
2024) In Annals of Allergy, Asthma and Immunology(
- Contribution to journal › Article
-
Mark
Association between pre-biologic T2-biomarker combinations and response to biologics in patients with severe asthma
(
- Contribution to journal › Article
-
Mark
Disease burden and unmet need for acute allergic reactions – A patient perspective
(
- Contribution to journal › Article
-
Mark
Expression of Stress-Induced Genes in Bronchoalveolar Lavage Cells and Lung Fibroblasts from Healthy and COPD Subjects
(
- Contribution to journal › Article
-
Mark
Altered hypoxia-induced cellular responses and inflammatory profile in lung fibroblasts from COPD patients compared to control subjects
(
- Contribution to journal › Article
-
Mark
Multi-Disciplinary Expert Perspective on the Management of Type 2 Inflammation-Driven Severe CRSwNP : A Brief Overview of Pathophysiology and Recent Clinical Insights
(
- Contribution to journal › Article
-
Mark
Exploring Definitions and Predictors of Response to Biologics for Severe Asthma
2024) In Journal of Allergy and Clinical Immunology: In Practice(
- Contribution to journal › Article
-
Mark
Expiratory and inspiratory resistance and reactance from respiratory oscillometry defining expiratory flow limitation in obstructive lung diseases
2024) In Clinical Physiology and Functional Imaging(
- Contribution to journal › Article
-
Mark
Treatment Preferences for Acute Allergic Reactions : A Discrete Choice Experiment
(
- Contribution to journal › Article
- 2023
-
Mark
Clusters based on immune markers in a Lithuanian asthma cohort study
(
- Contribution to journal › Article
-
Mark
Lung function deficits and bronchodilator responsiveness at 12 years of age in children born very preterm compared with controls born at term
(
- Contribution to journal › Article
-
Mark
A EUFOREA comment on a lost comorbidity of asthma
(
- Contribution to journal › Letter
-
Mark
Multidisciplinary approaches to identifying and managing global airways disease : Expert recommendations based on qualitative discussions
(
- Contribution to journal › Article
-
Mark
Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in patients with severe asthma eligible for both
(
- Contribution to journal › Article
-
Mark
EUFOREA summit in Brussels 2023 : inspiring the future of allergy & respiratory care
(
- Contribution to journal › Article
-
Mark
Impact of Inititing Biologics in Patients With Severe Asthma on Long-term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry
(
- Contribution to journal › Article
-
Mark
Biologics in severe asthma : A pragmatic approach for choosing the right treatment for the right patient
(
- Contribution to journal › Article
-
Mark
How can the findings of the EMAX trial on long-acting bronchodilation in chronic obstructive pulmonary disease be applied in the primary care setting?
(
- Contribution to journal › Scientific review
-
Mark
Lung Fibroblasts from Chronic Obstructive Pulmonary Disease Subjects Have a Deficient Gene Expression Response to Cigarette Smoke Extract Compared to Healthy
(
- Contribution to journal › Article
-
Mark
Limited beneficial effects of systemic steroids when added to standard of care treatment of seasonal allergic rhinitis
(
- Contribution to journal › Article
-
Mark
EUFOREA pocket guide on the diagnosis and management of asthma : An educational and practical tool for general practitioners, non-respiratory physicians, paramedics and patients
(
- Contribution to journal › Article
-
Mark
Neutrophil phenotypes in bronchial airways differentiate single from dual responding allergic asthmatics
(
- Contribution to journal › Article
-
Mark
Eosinophils and tissue remodeling : Relevance to airway disease
(
- Contribution to journal › Scientific review
- 2022
-
Mark
Cysteinyl–leukotriene and prostaglandin pathways in bronchial versus alveolar lavage in allergic asthmatics
(
- Contribution to journal › Letter
-
Mark
Ciliated (FOXJ1+) Cells Display Reduced Ferritin Light Chain in the Airways of Idiopathic Pulmonary Fibrosis Patients
(
- Contribution to journal › Article
-
Mark
Plasma proteome changes linked to late phase response after inhaled allergen challenge in asthmatics
(
- Contribution to journal › Article
-
Mark
Characterization of Patients in the International Severe Asthma Registry with High Steroid Exposure Who Did or Did Not Initiate Biologic Therapy
(
- Contribution to journal › Article
-
Mark
Applying key learnings from the EMAX trial to clinical practice and future trial design in COPD
(
- Contribution to journal › Scientific review
-
Mark
Allergen provocation tests in respiratory research : building on 50 years of experience
(
- Contribution to journal › Article
-
Mark
Histology-based blood leukocyte profiling reveals parallel Th2 and Th17 signatures in seasonal allergic rhinitis
(
- Contribution to journal › Article
-
Mark
Single-nucleotide polymorphisms in the sulfatase-modifying factor 1 gene are associated with lung function and COPD
(
- Contribution to journal › Article
- 2021
-
Mark
ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice
(
- Contribution to journal › Scientific review
-
Mark
Cognitive dysfunction and quality of life during pollen season in children with seasonal allergic rhinitis
(
- Contribution to journal › Article
-
Mark
Dual bronchodilator therapy as first-line treatment in maintenance-naïve patients with symptomatic copd : A pre-specified analysis of the emax trial
(
- Contribution to journal › Article
-
Mark
Lung Mast Cells Have a High Constitutive Expression of Carboxypeptidase A3 mRNA That Is Independent from Granule-Stored CPA3
(
- Contribution to journal › Article
-
Mark
Perinatal inflammation relates to early respiratory morbidity and lung function at 12 years of age in children born very preterm
(
- Contribution to journal › Article
-
Mark
Effect of nocturnal Temperature-controlled Laminar Airflow on the reduction of severe exacerbations in patients with severe allergic asthma : a meta-analysis
(
- Contribution to journal › Article
-
Mark
Human Primary Airway Basal Cells Display a Continuum of Molecular Phases from Health to Disease in Chronic Obstructive Pulmonary Disease
(
- Contribution to journal › Article
-
Mark
A new protocol for exercise testing in COPD; improved prediction algorithm for WMAX and validation of the endurance test in a placebo-controlled double bronchodilator study
(
- Contribution to journal › Article
-
Mark
Efficacy of umeclidinium/vilanterol according to the degree of reversibility of airflow limitation at screening : a post hoc analysis of the EMAX trial
(
- Contribution to journal › Article
-
Mark
ERS/EAACI statement on adherence to international adult asthma guidelines
(
- Contribution to journal › Scientific review
-
Mark
Wtreatment of copd with long-acting bronchodilators : Association between early and longer-term clinically important improvement
(
- Contribution to journal › Article
-
Mark
Efficacy and Safety of Umeclidinium/Vilanterol in Current and Former Smokers with COPD : A Prespecified Analysis of The EMAX Trial
(
- Contribution to journal › Article
-
Mark
Impaired differentiation of chronic obstructive pulmonary disease bronchial epithelial cells grown on bronchial scaffolds
(
- Contribution to journal › Article
-
Mark
Crosstalk between mast cells and lung fibroblasts is modified by alveolar extracellular matrix and influences epithelial migration
(
- Contribution to journal › Article
-
Mark
Immune modulation via T regulatory cell enhancement : Disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases—An EAACI position paper of the Task Force on Immunopharmacology (TIPCO)
(
- Contribution to journal › Article
-
Mark
Non-exacerbating patients with COPD from a UK perspective using the galaxy model
(
- Contribution to journal › Article
-
Mark
Eosinophilic and Noneosinophilic Asthma : An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma Cohort
(
- Contribution to journal › Article
- 2020
-
Mark
Usability of mepolizumab single-use prefilled syringe for patient self-administration
(
- Contribution to journal › Article
-
Mark
Eosinophils, basophils, and type 2 immune microenvironments in COPD-affected lung tissue
(
- Contribution to journal › Article
-
Mark
Salbutamol use in relation to maintenance bronchodilator efficacy in COPD : a prospective subgroup analysis of the EMAX trial
(
- Contribution to journal › Article
-
Mark
Converging pathways in pulmonary fibrosis and Covid-19 - The fibrotic link to disease severity : Common molecular pathways in Covid-19 and pulmonary fibrosis
(
- Contribution to journal › Article
-
Mark
Type 2 inflammatory biomarker response after exercise challenge testing
(
- Contribution to journal › Article
-
Mark
Fractional exhaled breath temperature in patients with asthma, chronic obstructive pulmonary disease, or systemic sclerosis compared to healthy controls
(
- Contribution to journal › Article
-
Mark
VEGF synthesis and VEGF receptor 2 expression in patients with bronchiolitis obliterans syndrome after lung transplantation
(
- Contribution to journal › Article
-
Mark
A new maximal bicycle test using a prediction algorithm developed from four large COPD studies
(
- Contribution to journal › Article
-
Mark
Clinical characteristics of the BREATHE cohort–a real-life study on patients with asthma and COPD
(
- Contribution to journal › Article
-
Mark
International severe asthma registry (ISAR) : protocol for a global registry
(
- Contribution to journal › Article
-
Mark
A new role for “eat me” and “don’t eat me” markers on neutrophils in asthmatic airway inflammation
(
- Contribution to journal › Letter
-
Mark
Point-of-care biomarkers in asthma management : Time to move forward
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Allergic respiratory disease care in the COVID-19 era : A EUFOREA statement
(
- Contribution to journal › Letter
-
Mark
Clinical and daily respiratory care and clinical trials within the COVID-19 era
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Early and sustained symptom improvement with umeclidinium/vilanterol versus monotherapy in COPD : a post hoc analysis of the EMAX randomised controlled trial
(
- Contribution to journal › Article
-
Mark
The risk of osteoporosis in patients with asthma
(
- Contribution to journal › Scientific review
-
Mark
Nordstar : Paving the way for a new era in asthma research
(
- Contribution to journal › Article
-
Mark
Impact of baseline COPD symptom severity on the benefit from dual versus mono-bronchodilators : an analysis of the EMAX randomised controlled trial
(
- Contribution to journal › Article
-
Mark
Real-life assessment of chronic rhinosinusitis patients using mobile technology : The mySinusitisCoach project by EUFOREA
(
- Contribution to journal › Article
-
Mark
Aligning the good practice mask with the objectives of the European innovation partnership on active and healthy ageing
(
- Contribution to journal › Article
-
Mark
Reduced variability of endurance time in new protocols for exercise tests in COPD
(
- Contribution to journal › Article
- 2019
-
Mark
The REal Life EVidence AssessmeNt Tool (RELEVANT) : Development of a novel quality assurance asset to rate observational comparative effectiveness research studies
(
- Contribution to journal › Article
-
Mark
Quality standards in respiratory real-life effectiveness research : The REal Life EVidence AssessmeNt Tool (RELEVANT): Report from the Respiratory Effectiveness Group - European Academy of Allergy and Clinical Immunology Task Force
(
- Contribution to journal › Article
-
Mark
Val av inhalator är av stor vikt vid behandling av astma och KOL
(
- Contribution to journal › Article
-
Mark
Expression, activity and localization of lysosomal sulfatases in Chronic Obstructive Pulmonary Disease
(
- Contribution to journal › Article
-
Mark
Osteopontin protects against pneumococcal infection in a murine model of allergic airway inflammation
(
- Contribution to journal › Article
-
Mark
Mast Cell-Mediated Orchestration of the Immune Responses in Human Allergic Asthma : Current Insights
(
- Contribution to journal › Article
-
Mark
Targeting lipid mediators in asthma : time for reappraisal
(
- Contribution to journal › Article
-
Mark
Time to onset of improvements in Quality of Life from Temperature-controlled Laminar Airflow (TLA) in severe allergic asthma
(
- Contribution to journal › Article
-
Mark
Effects of baseline symptom burden on treatment response in COPD
(
- Contribution to journal › Article
-
Mark
Comparing biologicals and small molecule drug therapies for chronic respiratory diseases : An EAACI Taskforce on Immunopharmacology position paper
(
- Contribution to journal › Article
-
Mark
Much ado about Biologicals : Highlights of the Master Class on Biologicals, Prague, 2018
(
- Contribution to journal › Letter
-
Mark
Comparison of Normal and Metaplastic Epithelium in Patients with Stable versus Persistently Symptomatic Severe Asthma Using Laser-Capture Microdissection and Data-Independent Acquisition–Mass Spectrometry
(
- Contribution to journal › Article
-
Mark
Prevalence and characteristics of asthma-chronic obstructive pulmonary disease overlap in routine primary care practices
(
- Contribution to journal › Article
-
Mark
EUFOREA consensus on biologics for CRSwNP with or without asthma
(
- Contribution to journal › Scientific review
-
Mark
Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
(
- Contribution to journal › Article
-
Mark
Matrisome Properties of Scaffolds Direct Fibroblasts in Idiopathic Pulmonary Fibrosis
(
- Contribution to journal › Article
-
Mark
Efficacy and safety of a first-in-class inhaled PDE3/4 inhibitor (ensifentrine) vs salbutamol in asthma
(
- Contribution to journal › Article
-
Mark
The potential role of CD16highCD62Ldim neutrophils in the allergic asthma
(
- Contribution to journal › Letter
-
Mark
The complex pathophysiology of allergic rhinitis : Scientific rationale for the development of an alternative treatment option
(
- Contribution to journal › Scientific review
-
Mark
Severe asthma: Entering an era of new concepts and emerging therapies: Highlights of the 4th international severe asthma forum, Madrid, 2018
(
- Contribution to journal › Article
-
Mark
Oxidative Stress Attenuates TLR3 Responsiveness and Impairs Anti-viral Mechanisms in Bronchial Epithelial Cells From COPD and Asthma Patients
(
- Contribution to journal › Article
-
Mark
Expression of Different VEGF Isoforms and Receptors in Primary Distal Lung Fibroblasts and Lung Explants from Patients with COPD
(
- Contribution to journal › Published meeting abstract
- 2018
-
Mark
Quantitative proteomic characterization of the lung extracellular matrix in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis
(
- Contribution to journal › Article
-
Mark
Endoplasmic reticulum, Golgi, and lysosomes are disorganized in lung fibroblasts from chronic obstructive pulmonary disease patients
(
- Contribution to journal › Article
-
Mark
Interferon-β deficiency at asthma exacerbation promotes MLKL mediated necroptosis
(
- Contribution to journal › Article
-
Mark
Real-world effectiveness evaluation of budesonide/formoterol Spiromax for the management of asthma and chronic obstructive pulmonary disease in the UK
(
- Contribution to journal › Article
-
Mark
Mast cells and mast cell tryptase enhance migration of human lung fibroblasts through protease-activated receptor 2
(
- Contribution to journal › Article